AstraZeneca has reportedly withdrawn its COVID-19 vaccine worldwide, citing a 'surplus in available updated vaccines in the market.' This comes weeks after the pharmaceutical giant admitted in court documents that their Covishield and Vaxzevria vaccines can, in rare cases, cause a condition called Thrombosis Thrombocytopenia Syndrome (TTS).